Moinuddin .

Dr. Moinuddin .


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2024 in Cells
Verified
Journal Article
Open access
PDF file
MMMohd Mustafa
Mohd Mustafa
RARizwan Ahmad
Rizwan Ahmad
ITIrfan Qadir Tantry
Irfan Qadir Tantry
WAWALEEM AHMAD
WALEEM AHMAD
SSSana Siddiqui
Sana Siddiqui
SISidra Islam
Sidra Islam
Cell survival and death are intricately governed by apoptosis, a meticulously controlled programmed cell death. Apoptosis is vital in facilitating embryonic development and maintaining tissue homeostasis and immunological functioning. It is a complex interplay of intrinsic and extrinsic signaling pathways that ultimately converges on executing the apoptotic program. The extrinsic pathway is initiated by the binding of death ligands such as TNF-α and Fas to their respective receptors on the cell surface. In contrast, the intrinsic pathway leads to increased permeability of the outer mitochondrial membrane and the release of apoptogenic factors like cytochrome c, which is regulated by the Bcl-2 family of proteins. Once activated, these pathways lead to a cascade of biochemical events, including caspase activation, DNA fragmentation, and the dismantling of cellular components. Dysregulation of apoptosis is implicated in various disorders, such as cancer, autoimmune diseases, neurodegenerative disorders, and cardiovascular diseases. This article focuses on elucidating the molecular mechanisms underlying apoptosis regulation, to develop targeted therapeutic strategies. Modulating apoptotic pathways holds immense potential in cancer treatment, where promoting apoptosis in malignant cells could lead to tumor regression. This article demonstrates the therapeutic potential of targeting apoptosis, providing options for treating cancer and neurological illnesses. The safety and effectiveness of apoptosis-targeting drugs are being assessed in ongoing preclinical and clinical trials (phase I–III), opening the door for more effective therapeutic approaches and better patient outcomes.

1 November 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SISidra Islam
Sidra Islam
M.Moinuddin .
Moinuddin .
AMAbdul Rouf Mir
Abdul Rouf Mir
MAMir Yasir Arfat
Mir Yasir Arfat
KAKhursheed Alam
Khursheed Alam
AAAsif Ali
Asif Ali

1 May 2018 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
MAMinhal Abidi
Minhal Abidi
MKM. Salman Khan
M. Salman Khan
Saheem AhmadSaheem Ahmad
Saheem Ahmad
TKTasneem Kausar
Tasneem Kausar
SNShahid M. Nayeem
Shahid M. Nayeem
M.Moinuddin .
Moinuddin .

1 October 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SISidra Islam
Sidra Islam
AMAbdul Rouf Mir
Abdul Rouf Mir
MAMinhal Abidi
Minhal Abidi
MTMohd Talha
Mohd Talha
AZAtif Zafar
Atif Zafar
M.Moinuddin .
Moinuddin .

1 July 2021 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
MTMohd Talha
Mohd Talha
AMAbdul Rouf Mir
Abdul Rouf Mir
SHSafia Habib
Safia Habib
MAMinhal Abidi
Minhal Abidi
MWMohd Sharib Warsi
Mohd Sharib Warsi
M.Moinuddin .
Moinuddin .

1 April 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SPShahida Perween
Shahida Perween
MAMinhal Abidi
Minhal Abidi
AFAbul Faiz Faizy
Abul Faiz Faizy
M.Moinuddin .
Moinuddin .